MAPPI: Market Access Potential and Price Index Tool

Evaluates the Market Access Potential of Early Stage Assets (Prior to Phase III)
Provides a global answer by focusing on payer value elements found across health care systems
- Developed with Payers and validated through more than 30 products
- Mimics Health Technology Assessment bodies and payers’ evaluation processes
Questions and/or calls attention on critical NPV assumptions: price, reimbursed population definition, development spent, time to reimbursement
Results are not stored and remain completely confidential

Completing the data fields below is optional, data is only used for outcome pages or for contact information if there is a wish to be on the groupH mailing list. To use the tool, click below and simply complete the evaluation process for your product:

First Name	Company	Product Name
Last Name	Function	Indication
E-mail Address		If you want the product and indication to appear on outcome pages